Myoclonus‐dystonia due to genomic deletions in the epsilon‐sarcoglycan gene
- 20 October 2005
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 58 (5) , 792-797
- https://doi.org/10.1002/ana.20661
Abstract
Direct genomic DNA sequencing fails to detect epsilon‐sarcoglycan (SGCE) mutations in up to 30% of familial myoclonus‐dystonia (M‐D) cases. We identified novel large heterozygous deletions of SGCE exon 5 or exon 6 in two M‐D pedigrees. Like nonsense mutations, exon rearrangements result in the generation of premature stop codons downstream of the deleted exon. SGCE exon dosage assays may identify additional families with SGCE mutation and thus reduce “genetic heterogeneity.” Ann Neurol 2005;58:792–797Keywords
This publication has 17 references indexed in Scilit:
- The epsilon-sarcoglycan gene in myoclonic syndromesNeurology, 2005
- Myoclonus–dystonia: Detection of novel, recurrent, and de novo SGCE mutationsNeurology, 2004
- Clinical and genetic features of myoclonus-dystonia in 3 cases: A video presentationMovement Disorders, 2004
- An Alu Transposition Model for the Origin and Expansion of Human Segmental DuplicationsAmerican Journal of Human Genetics, 2003
- Mechanism and regulation of human non-homologous DNA end-joiningNature Reviews Molecular Cell Biology, 2003
- Analysis of the ϵ‐sarcoglycan gene in familial and sporadic myoclonus‐dystonia: Evidence for genetic heterogeneityMovement Disorders, 2003
- The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprintedEuropean Journal of Human Genetics, 2003
- Myoclonus–dystonia syndrome: ε‐sarcoglycan mutations and phenotypeAnnals of Neurology, 2002
- Myoclonus dystoniaNeurology, 2002
- The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonismHuman Molecular Genetics, 2001